Sean Lee CFA
Stock Analyst at H.C. Wainwright
(0.51)
# 4,104
Out of 4,476 analysts
255
Total ratings
29.5%
Success rate
-2.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings | Reiterated: Buy | $14 | $5.48 | +155.47% | 9 | Jun 24, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $18 | $13.25 | +35.85% | 12 | Jun 4, 2026 | |
| DWTX Dogwood Therapeutics | Reiterated: Buy | $12 | $1.49 | +705.37% | 25 | May 19, 2026 | |
| CRVS Corvus Pharmaceuticals | Reiterated: Buy | $27 | $15.23 | +77.28% | 8 | May 15, 2026 | |
| CTSO Cytosorbents | Reiterated: Hold | $0.75 | $0.39 | +92.31% | 30 | May 14, 2026 | |
| MYO Myomo | Reiterated: Buy | $5 | $1.03 | +385.44% | 9 | May 8, 2026 | |
| ATEC Alphatec Holdings | Reiterated: Buy | $24 | $8.92 | +169.06% | 31 | May 7, 2026 | |
| NVAX Novavax | Reiterated: Buy | $16 | $9.74 | +64.27% | 6 | Apr 21, 2026 | |
| AKTX Akari Therapeutics, | Reiterated: Buy | $27 | $10.41 | +159.37% | 4 | Apr 21, 2026 | |
| PSTV Plus Therapeutics | Reiterated: Buy | $25 | $3.98 | +528.14% | 28 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.1469 | +2,622.94% | 20 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $4.50 | +211.11% | 35 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €14.00 | $3.73 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.81 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $97.79 | n/a | 18 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Mar 21, 2025 |
Senseonics Holdings
Jun 24, 2026
Reiterated: Buy
Price Target: $14
Current: $5.48
Upside: +155.47%
Kazia Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $13.25
Upside: +35.85%
Dogwood Therapeutics
May 19, 2026
Reiterated: Buy
Price Target: $12
Current: $1.49
Upside: +705.37%
Corvus Pharmaceuticals
May 15, 2026
Reiterated: Buy
Price Target: $27
Current: $15.23
Upside: +77.28%
Cytosorbents
May 14, 2026
Reiterated: Hold
Price Target: $0.75
Current: $0.39
Upside: +92.31%
Myomo
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $1.03
Upside: +385.44%
Alphatec Holdings
May 7, 2026
Reiterated: Buy
Price Target: $24
Current: $8.92
Upside: +169.06%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $9.74
Upside: +64.27%
Akari Therapeutics,
Apr 21, 2026
Reiterated: Buy
Price Target: $27
Current: $10.41
Upside: +159.37%
Plus Therapeutics
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $3.98
Upside: +528.14%
Dec 9, 2025
Maintained: Buy
Price Target: $4
Current: $0.1469
Upside: +2,622.94%
Nov 5, 2025
Reiterated: Buy
Price Target: $14
Current: $4.50
Upside: +211.11%
May 7, 2025
Maintained: Buy
Price Target: €14.00
Current: $3.73
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $11
Current: $1.81
Upside: n/a
Apr 1, 2025
Maintained: Buy
Price Target: $40
Current: $97.79
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a